New Zeposia Data Highlight COVID-19 Outcomes and Preservation of Long-Term Cognitive Function from Separate Analyses in Patients with Relapsing Forms of Multiple Sclerosis Pharmaceutical Investing
The Robert A. Winn Diversity in Clinical Trials Award Program Announces the Second Group of Physicians to be Trained in the $114 Million Program Pharmaceutical Investing
Ginkgo Bioworks and the Ministry of Investment of Saudi Arabia Announce Plans to Develop Biosecurity and Biotechnology Capabilities for Global Public Health Life Science Investing
Seelos Therapeutics Doses First Patient in a Registrational Phase II/III study of SLS-005 in Spinocerebellar Ataxia Psychedelics Investing
Cardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart Diseases Pharmaceutical Investing
Medtronic chairman and CEO Geoff Martha to speak at the CECP's CEO Investor Forum Medical Device Investing
Salix Will Present XIFAXAN , TRULANCE and RELISTOR Data at The American College of Gastroenterology 2022 Annual Scientific Meeting Pharmaceutical Investing
AbbVie to Present Data from Extensive Portfolio at American College of Gastroenterology Annual Scientific Meeting Pharmaceutical Investing
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
